4.7 (2023) 5-year Journal Impact Factor 5.0 (2023) Submission to first decision (median) 4 days Downloads 572,849 (2023) Latest articles Talimogene laherparepvec (T-VEC) and Emerging Intralesional Immunotherapies for Metastatic Melanoma: A Review ...
2023–2024 Article Series of the Canadian Association of General Practitioners in Oncology Guest Editor: Genevieve ChaputDeadline: 31 December 2024 Special Issue in Current Oncology Biliary Tract Cancer Updates: Advancements and Insights Guest Editor: Kristen R. SpencerDeadline: 31 December 2024 Special...
当前的肿瘤学(Current Oncology)是一本由Multimed Inc.出版的一本ONCOLOGY学术刊物,主要报道ONCOLOGY相关领域研究成果与实践。本刊已入选来源期刊,该刊创刊于1994年,出版周期Bimonthly。2021-2022年最新版WOS分区等级:Q2,2023年发布的影响因子为2.8。
Current Oncology 期刊介绍 期刊为临床肿瘤学家报告和审查肿瘤疾病管理进展的多学科期刊,目前已被 SCIE、Scopus、PubMed 等重要数据库收录。 2023 Impact Factor: 2.8 2023 CiteScore: 3.3
Year Impact Factor (IF) Total Articles Total Cites 2023 (2024 update) 3.8 - - 2022 4.3 - 3162 2021 5.080 - 2884 2020 5.036 99 2418 2019 3.900 88 1617 2018 3.851 78 1406 2017 3.562 71 1242 2016 2.820 63 1047 2015 2.127 58 848 2014 2.822 53 763 2013 3.240 49 791 2012 2.422 41 ...
学科:ONCOLOGYSCIEQ2151 / 322 53.26% 名词解释: 汤森路透每年出版一本《期刊引用报告》(Journal Citation Reports,简称JCR)。JCR对86000多种SCI期刊的影响因子(Impact Factor)等指数加以统计。JCR将收录期刊分为176个不同学科类别在JCR的Journal Ranking中,主要参考当年IF,最终每个分区的期刊数量是均分的。
“Editor's Choice Articles”是由期刊主编团队根据文章质量,话题关注度和科学创新性选出的优秀文章合集。继上期编辑荐读,本期继续推荐5篇Current Oncology期刊的精选文章,内容涉及肿瘤的免疫与放射治疗以及心理肿瘤学等方面,希望能为相关领...
5-year Journal Impact Factor 6.0 (2023) Submission to first decision (median) 4 days Downloads 645,636 (2023) Latest articles Special Considerations in the Treatment of Idiopathic Intracranial Hypertension Deborah I. Friedman Review10 December 2024Article: 8 ...
目前肿瘤学的治疗方案(Current Treatment Options In Oncology)是一本由Springer US出版的一本ONCOLOGY学术刊物,主要报道ONCOLOGY相关领域研究成果与实践。本刊已入选来源期刊,该刊创刊于2000年,出版周期Bimonthly。2021-2022年最新版WOS分区等级:Q2,2023年发布的影响因子为3.8,CiteScore指数7.1,SJR指数1.326。本刊非开放...
Annals of Hematology & Oncology is an open access, peer reviewed, scholarly journal dedicated to publish articles in all areas of Hematology & Oncology.